Background.: Protamine sulfate, which is used for heparin neutralization, has been reported to induce catastrophic pulmonary vasoconstriction after infusion. However, in the systemic circulation, protamine infusion induces hypotension due to peripheral vasodilatation. Methods.: To determine whether protamine also could induce vasodilatation in the pulmonary circulation, third-order canine pulmonary artery segments were studied in vitro in organ chambers. Results.: In pulmonary artery segments that were caused to contract with phenylephrine (10-5 mol/L), protamine sulfate (40 to 400 μg/mL, final organ bath concentration) produced concentration-dependent relaxation in canine pulmonary artery segments with endothelium (to 74% ± 7% of the initial contraction to phenylephrine) that was significantly greater (p < 0.05) than in segments without endothelium (30% ± 6% of the initial phenylephrine contraction). Pretreatment of arterial segments with NG-monomethyl-l-arginine (10-5 mol/L), the competitive inhibitor of nitric oxide synthesis from l-arginine, did not change tension of arterial segments, but NG-monomethyl-l-arginine attenuated the relaxation to protamine. The inhibitory effect of NG-monomethyl-l-arginine could be reversed by the addition of l-arginine (10-4 mol/L) but not d-arginine (10-4 mol/L). Endothelium-dependent vasodilation to protamine (40 to 400 μg/mL) also could be inhibited by heparin (8 U/mL, final organ bath concentration). However, the inhibitory effect of heparin could be overcome by adding higher concentrations of protamine. Conclusions.: Protamine-mediated pulmonary vasodilatation could be an important mechanism to protect against the constrictive effects of autocoids generated during heparin neutralization. Such a mechanism might be dysfunctional in certain persons and put them at risk for pulmonary vasoconstriction after protamine infusion.
ASJC Scopus subject areas
- Pulmonary and Respiratory Medicine
- Cardiology and Cardiovascular Medicine